Lineage Cell Therapeutics, Inc. (LCTX)
0.82
-0.02
(-2.21%)
USD |
NYAM |
Nov 19, 16:00
0.841
+0.02
(+2.56%)
After-Hours: 07:16
Lineage Cell Therapeutics Price : 0.82 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 0.8366 | 0.85 | 0.82 | 0.82 | 1.312M |
| Nov 18, 2026 | 0.8166 | 0.86 | 0.8152 | 0.8385 | 1.221M |
| Nov 17, 2026 | 0.82 | 0.8755 | 0.7697 | 0.8158 | 6.790M |
| Nov 16, 2026 | 0.94 | 0.95 | 0.77 | 0.7951 | 12.78M |
| Nov 13, 2026 | 0.9901 | 1.02 | 0.8902 | 0.9146 | 2.078M |
| Nov 12, 2026 | 1.10 | 1.125 | 0.9902 | 0.9903 | 1.378M |
| Nov 11, 2026 | 1.03 | 1.13 | 1.00 | 1.11 | 1.717M |
| Nov 10, 2026 | 1.06 | 1.07 | 1.03 | 1.04 | 1.152M |
| Nov 09, 2026 | 1.01 | 1.09 | 0.9963 | 1.08 | 974454.0 |
| Nov 06, 2026 | 0.9644 | 1.03 | 0.9644 | 1.02 | 1.032M |
| Nov 05, 2026 | 1.03 | 1.03 | 0.9664 | 0.9831 | 2.354M |
| Nov 04, 2026 | 1.03 | 1.065 | 1.012 | 1.03 | 965030.0 |
| Nov 03, 2026 | 1.02 | 1.035 | 0.9874 | 1.01 | 919890.0 |
| Nov 02, 2026 | 1.01 | 1.02 | 0.9753 | 1.01 | 1.723M |
| Oct 30, 2026 | 1.04 | 1.05 | 0.982 | 1.00 | 1.166M |
| Oct 29, 2026 | 1.05 | 1.06 | 1.02 | 1.03 | 937733.0 |
| Oct 28, 2026 | 1.03 | 1.045 | 1.01 | 1.04 | 1.077M |
| Oct 27, 2026 | 0.9925 | 1.04 | 0.9751 | 1.03 | 1.196M |
| Oct 26, 2026 | 1.00 | 1.01 | 0.9616 | 0.9969 | 1.908M |
| Oct 23, 2026 | 0.9657 | 1.015 | 0.9436 | 1.00 | 1.151M |
| Oct 22, 2026 | 0.9483 | 1.01 | 0.9401 | 0.985 | 1.347M |
| Oct 21, 2026 | 0.9865 | 0.9903 | 0.9376 | 0.9515 | 1.221M |
| Oct 20, 2026 | 0.9508 | 1.01 | 0.9508 | 0.9726 | 1.631M |
| Oct 19, 2026 | 0.9809 | 0.9997 | 0.94 | 0.9528 | 955553.0 |
| Oct 16, 2026 | 0.98 | 1.00 | 0.96 | 0.9783 | 1.309M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Curis, Inc. | 0.4694 |
| Armata Pharmaceuticals, Inc. | 2.98 |
| Voyager Therapeutics, Inc. | 1.61 |
| Black Diamond Therapeutics, Inc. | 1.39 |
| Invivyd, Inc. | 0.4459 |
Price Related Metrics
| PS Ratio | 19.39 |
| Price to Book Value | 3.092 |
| Earnings Yield | -10.24% |
| Market Cap | 207.38M |